The U.S. Food and Drug Administration (FDA) and some physicians are cautioning about the possible dangers of using “knock-off brands” of semaglutides, which are part of the GLP-1 class of drugs.
The trend has “concerned” Dr. Brett Osborn, a neurosurgeon and longevity specialist from Florida who has been prescribing pharmaceutical-grade versions of these drugs since 2019.
A PUSH FOR OZEMPIC SENIORS? More people 65 and older should be on it, according to some doctors.
He told News that because brand-name Ozempic is so expensive, more and more people are using less expensive knockoffs, which are frequently available online or through unregulated means.
Osborn cautioned that if the source or quality of production of these drugs is not monitored, there is a chance they could be dangerous.
During surgery, ozempic patients may be at risk.
You can’t be sure what you’re taking into your body when they’re produced in unregulated circumstances.
New York City weight-loss specialist Dr. Sue Decotiis, MD, acknowledged that some people are looking for less expensive options but pointed out that more people are becoming aware of their possible risks.
